(Q46899237)

English

Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy

scientific article published in March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

object named as

S Emery

7

0 references

author name string

A Winston

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

Pwg Mallon

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

D Marriott

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

A Carr

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

D A Cooper

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

105-111

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Fanconi syndrome and renal failure induced by tenofovir: a first case report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Tenofovir-related nephrotoxicity: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Renal lesions in HIV-1-positive patient treated with tenofovir

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Fanconi syndrome and acute renal failure in a patient treated with tenofovir: a call for caution

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Renal safety of tenofovir in HIV treatment-experienced patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Role of hepatitis B virus infection in pathogenesis of IgA nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Hepatitis C infection associated with renal disease and chronic renal failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00349.X

21 January 2018

Identifiers

10.1111/J.1468-1293.2006.00349.X

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420255

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46899237&oldid=2136989814"